Assessing sirtuin expression in endometrial carcinoma and non neoplastic endometrium
Sirtuins participate in hormone imbalance, metabolism and aging, which are important processes for endometrial cancer (EC) development. Sirtuins mRNA expression (SIRT1 to 7) was determined in 76 ECs (63 Type I, 12 Type II and one mixed EC) and 30 non neoplastic endometria (NNE) by quantitative real time PCR. SIRT1 and SIRT7 protein expression was evaluated by immunohistochemistry using Allred score. Compared to NNE, ECs showed SIRT7 (p 0.001) mRNA overexpression, whereas SIRT1 (p 0.001) SIRT2 (p 0.001) SIRT4 (p 0.001) and SIRT5 (p 0.001) were underexpressed. No significant differences were observed for SIRT3 and SIRT6. Type II ECs displayed lower SIRT1 (p 0.032) and SIRT3 (p 0.016) transcript levels than Type I ECs. Concerning protein expression, SIRT1 immunostaining median score was higher in ECs compared to NNE epithelium (EC 5 vs. NNE 2, p 0.001) while SIRT7 was lower in ECs (EC 6 vs. NNE 7, p 0.001) No significant associations were found between SIRT1/7 immunoexpression and histological subtype, grade, lymphovascular invasion or stage. Our data shows that sirtuins are deregulated in EC. The diversity of expression patterns observed suggests that sirtuins may have distinctive roles in endometrial cancer similarly to what has been described in other cancer models.
Oncotarget